Form 8-K - Current report:
SEC Accession No. 0001213900-20-015104
Filing Date
2020-06-16
Accepted
2020-06-16 16:21:18
Documents
2
Period of Report
2020-06-16
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea123121-8k_actiniumpharma.htm 8-K 17776
2 CERTIFICATE OF AMENDMENT TO CERTIFICATE OF INCORPORATION OF ACTINIUM PHARMACEUTI ea123121ex3-1_actiniumpharma.htm EX-3.1 6247
  Complete submission text file 0001213900-20-015104.txt   25263
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36374 | Film No.: 20966730
SIC: 2834 Pharmaceutical Preparations